Market Place
Sourcing Support
Allysta Pharma Announces Completion of Enrollment in Ph2b/3 Trial (OASIS-1)
08 Nov 2022 //
ACCESSWIRE
Allysta Announces Initiation of Dosing in OASIS-1 Phase 2b/3 Clinical Trial
22 Jun 2021 //
ACCESSWIRE
Allysta Pharma Announces Start of Phase 1 Clinical Trial of ALY688-SR
10 Jun 2021 //
ACCESSWIRE
Allysta Pharmaceuticals, Inc. Announces Positive Preclinical Data
16 Dec 2020 //
ACCESSWIRE
Allysta nnounces Positive Results from its Phase 1/2a Clinical Trial of ALY688
01 Dec 2020 //
ACCESSWIRE
Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Solution
08 Jan 2020 //
PRESS RELEASE
Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Solution
07 Jan 2020 //
PRESS RELEASE
Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Solution
07 Jan 2020 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.